Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 20.34%415.15M | -30.62%486.62M | -37.99%304.33M | -32.24%522.04M | -38.59%344.99M | 25.21%701.37M | -25.83%490.78M | 30.61%770.43M | 25.62%561.77M | 32.83%560.17M |
| Transactional financial assets | -12.66%670.48M | 62.13%757.69M | 57.63%894.15M | 66.59%670.25M | 35.58%767.7M | -26.72%467.34M | 7.66%567.25M | -35.25%402.35M | -23.88%566.22M | -19.40%637.72M |
| Notes receivable and accounts receivable | 8.32%425.6M | 9.74%384.96M | 13.48%426.7M | 15.83%415.22M | 23.16%392.91M | 30.22%350.81M | 33.59%376M | 45.73%358.48M | 43.66%319.02M | 45.26%269.39M |
| -Notes receivable | ---- | ---- | ---- | ---- | --300K | ---- | ---- | ---- | ---- | ---- |
| -Accounts receivable | 8.40%425.6M | 9.74%384.96M | 13.48%426.7M | 15.83%415.22M | 23.07%392.61M | 30.22%350.81M | 33.59%376M | 45.73%358.48M | 43.66%319.02M | 45.45%269.39M |
| Other receivables (including interest and dividends) | -28.86%4.69M | -32.49%4.24M | -42.26%4.86M | -13.32%5.39M | 17.46%6.59M | 3.10%6.28M | 55.24%8.41M | 17.19%6.22M | 8.30%5.61M | 67.73%6.09M |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | --6.33K | ---- | ---- | ---- |
| -Other receivable | ---- | -32.49%4.24M | ---- | -13.32%5.39M | ---- | 3.10%6.28M | ---- | 17.19%6.22M | ---- | 67.73%6.09M |
| Advance payment | 20.44%9.24M | 57.93%7.21M | 16.11%9.24M | 2.94%5.4M | 23.50%7.67M | 16.51%4.56M | 9.57%7.96M | -17.66%5.24M | 20.09%6.21M | 40.40%3.92M |
| Inventories | 48.36%86.84M | 34.62%72.96M | 19.90%69.47M | 16.82%62.56M | 7.66%58.53M | 15.09%54.2M | 10.68%57.94M | 11.03%53.55M | 8.97%54.37M | -4.81%47.09M |
| Non-current assets due within one year | ---- | ---- | ---- | -82.97%22.1M | -36.07%76.74M | -8.97%109.33M | 98.99%152.38M | 70.92%129.76M | 271.63%120.05M | --120.1M |
| Other current assets | 54.56%99.35M | 137.84%37.79M | 385.55%82.56M | 336.13%78.8M | 332.93%64.28M | 21.86%15.89M | 8.66%17M | 167.85%18.07M | 225.19%14.85M | 2.51%13.04M |
| Adjustment items of current assets | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total current assets | -0.47%1.71B | 2.44%1.75B | 6.77%1.79B | 2.16%1.78B | 4.33%1.72B | 3.15%1.71B | 3.10%1.68B | 9.02%1.74B | 9.13%1.65B | 12.99%1.66B |
| Non Current assets | ||||||||||
| Debt investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.03M | ---- |
| Other equity investment | 19.94%10.79M | 19.94%10.79M | 1,999.99%10.5M | 1,699.99%9M | 1,699.99%9M | 1,699.99%9M | --500K | --500K | --500K | --500K |
| Other non-current financial assets | -0.04%10.06M | -0.04%10M | --10.19M | --10.13M | --10.07M | --10M | ---- | ---- | ---- | ---- |
| Investment real estate | ---- | ---- | ---- | ---- | ---- | ---- | --7.95M | --7.97M | ---- | ---- |
| Fixed assets | ---- | 16.22%573.25M | ---- | -3.61%477.74M | ---- | 1.34%493.22M | ---- | 155.25%495.62M | ---- | 150.77%486.7M |
| Constru in process | ---- | -75.28%22.46M | ---- | 24.95%112.27M | ---- | 1.39%90.85M | ---- | -61.25%89.85M | ---- | -47.80%89.6M |
| Productive biological assets | 2.69%7.02M | 27.98%7.33M | 16.36%7.27M | 12.79%7.11M | -8.49%6.84M | -4.11%5.73M | -13.84%6.25M | 22.94%6.31M | 67.36%7.47M | 53.91%5.98M |
| Intangible assets | 48.41%72.05M | 45.52%71.37M | 6.78%49.05M | 1.36%47.56M | 1.51%48.55M | 3.60%49.05M | -3.23%45.93M | -0.92%46.93M | -0.92%47.83M | -2.42%47.34M |
| Development expenditure | -54.61%3.75M | -40.95%3.75M | -7.87%10.06M | 22.45%9.36M | --8.27M | --6.36M | --10.92M | --7.64M | ---- | ---- |
| Long deferred expense | -26.13%23.17M | -27.76%24.72M | -23.44%26.36M | -17.84%29.38M | -7.86%31.37M | -6.71%34.22M | 129.67%34.43M | 128.97%35.76M | 96.90%34.05M | 90.14%36.68M |
| Deferred tax assets | -13.04%33.47M | -7.90%33.14M | -3.70%41.69M | -7.35%39.6M | 5.48%38.49M | 12.97%35.98M | 118.00%43.29M | 131.22%42.74M | 109.56%36.49M | 86.86%31.85M |
| Usufruct assets | 29.36%85.29M | 148.64%90.68M | 49.33%58.05M | 41.28%58.91M | 48.28%65.93M | -14.42%36.47M | -6.34%38.87M | 3.44%41.7M | 5.91%44.46M | 673.06%42.62M |
| Other non current assets | 387.90%239.23M | 1,384.72%177.27M | 4,465.38%146.15M | 377.52%124.04M | -35.46%49.03M | -89.11%11.94M | -98.29%3.2M | -85.45%25.98M | -67.00%75.97M | -57.55%109.6M |
| Adjustment items of non current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 |
| Total non current assets | 24.17%1.16B | 29.06%1.11B | 21.37%1.04B | 16.85%1.02B | 2.22%931.54M | -6.22%862.87M | 0.59%855.81M | 8.70%870.08M | 12.00%911.32M | 16.95%920.07M |
| Total assets | 8.19%2.87B | 11.37%2.87B | 11.70%2.83B | 7.05%2.8B | 3.58%2.65B | -0.19%2.57B | 2.24%2.53B | 8.91%2.61B | 10.14%2.56B | 14.37%2.58B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 13.36%158.19M | 112.77%187.33M | 275.05%255.37M | 122.54%240.59M | 63.88%139.55M | 15.60%88.04M | -11.62%68.09M | 129.19%108.11M | 165.46%85.15M | 523.92%76.16M |
| Notes payable and accounts payable | 8.28%71.08M | -5.60%68.13M | -24.50%67.68M | -31.48%64.81M | -26.63%65.65M | -29.14%72.18M | 39.90%89.65M | 65.86%94.59M | 84.53%89.47M | 100.56%101.86M |
| -Accounts payable | 8.28%71.08M | -5.60%68.13M | -24.50%67.68M | -31.48%64.81M | -26.63%65.65M | -29.14%72.18M | 39.90%89.65M | 65.86%94.59M | 84.53%89.47M | 100.56%101.86M |
| Contract liabilities | 29.26%172.98M | 27.62%176.4M | 36.62%147.8M | 37.19%134.24M | 29.86%133.83M | 27.49%138.23M | 9.82%108.18M | 9.73%97.84M | 16.28%103.06M | 21.61%108.42M |
| Salaries payable | 3.29%29.11M | 4.92%52.52M | 5.98%39.78M | 3.10%33.28M | 0.93%28.18M | 14.62%50.06M | -15.98%37.54M | -11.92%32.28M | -7.46%27.92M | 2.75%43.68M |
| Taxs payable | 137.16%15.21M | 153.43%11.44M | 86.18%11.34M | -10.51%7.55M | -57.74%6.41M | -72.91%4.51M | -3.38%6.09M | 78.63%8.44M | 115.59%15.18M | 146.68%16.66M |
| Other payable (including interest and dividends) | -32.92%6.68M | -19.13%7.57M | -70.62%6.44M | -31.09%51.39M | 4.74%9.96M | -8.57%9.36M | 162.67%21.91M | 173.82%74.57M | 2.52%9.5M | 2.55%10.24M |
| -Dividend payable | ---- | ---- | ---- | -31.16%44.99M | ---- | ---- | --12.25M | 288.80%65.36M | ---- | ---- |
| -Other payable | ---- | -19.13%7.57M | ---- | -30.55%6.4M | ---- | -8.57%9.36M | ---- | -11.62%9.21M | ---- | 2.55%10.24M |
| Non current liabilities due within one year | 69.25%24.37M | 169.31%23.75M | 42.70%14.15M | 10.03%11.91M | 37.41%14.4M | -6.13%8.82M | 14.20%9.92M | 69.19%10.82M | 88.50%10.48M | 259.77%9.4M |
| Adjustment items of current assets | 0.00%-0.01 | ---- | --0.01 | ---- | -200.00%-0.01 | ---- | ---- | ---- | --0.01 | --0.01 |
| Total current liabilities | 20.01%477.62M | 42.01%527.14M | 58.93%542.56M | 27.45%543.76M | 16.79%397.98M | 1.31%371.2M | 10.97%341.38M | 58.98%426.64M | 54.03%340.77M | 71.16%366.41M |
| Current liabilities | ||||||||||
| Deferred tax liabilities | -2.79%7.72M | -3.29%7.93M | 18.69%9.75M | -11.78%9.01M | -18.27%7.94M | -12.86%8.2M | -30.38%8.21M | -2.16%10.21M | -5.45%9.72M | -4.96%9.41M |
| Long term deferred income | 26.51%26.86M | -1.49%22.56M | -24.14%18.82M | -23.39%20.49M | -46.08%21.23M | -44.20%22.9M | -37.38%24.81M | -36.26%26.75M | -11.13%39.37M | -16.21%41.04M |
| Lease liabilities | 24.33%76.95M | 125.24%80.23M | 61.59%57.88M | 53.33%57.32M | 61.43%61.89M | -1.25%35.62M | -0.89%35.82M | 2.24%37.38M | 2.29%38.34M | 1,083.92%36.07M |
| Total non current liabilities | 22.47%111.53M | 65.95%110.73M | 25.57%86.45M | 16.78%86.82M | 4.16%91.07M | -22.88%66.72M | -21.38%68.84M | -16.43%74.34M | -5.03%87.43M | 39.71%86.52M |
| Total liabilities | 20.47%589.15M | 45.66%637.87M | 53.33%629.01M | 25.87%630.58M | 14.21%489.04M | -3.31%437.92M | 3.80%410.23M | 40.20%500.99M | 36.67%428.2M | 64.10%452.93M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%410M | 0.00%410M | 0.00%410M | 0.00%410M | 0.00%410M | 0.00%410M | 0.00%410M | 0.00%410M | 0.00%410M | 0.00%410M |
| Capital reserve funds | -0.42%1.26B | -0.63%1.25B | -0.56%1.25B | -0.67%1.25B | 0.20%1.26B | 0.24%1.26B | 0.23%1.26B | 0.15%1.26B | 0.28%1.26B | 0.37%1.26B |
| Surplus reserve funds | 19.13%62.31M | 19.13%62.31M | 20.10%52.31M | 20.10%52.31M | 20.10%52.31M | 20.10%52.31M | 34.78%43.55M | 34.78%43.55M | 34.78%43.55M | 34.78%43.55M |
| Retained profit | 19.87%557.75M | 17.31%510.64M | 15.67%500.22M | 9.08%461.22M | 5.43%465.29M | 5.70%435.31M | 13.25%432.45M | 23.74%422.83M | 41.45%441.33M | 46.57%411.85M |
| Less:Treasury stock | -55.28%16.02M | -50.97%16.02M | -4.04%22.9M | -38.29%14.73M | 50.06%35.82M | --32.67M | --23.87M | --23.87M | --23.87M | ---- |
| Other composite income | 0.05%8.55M | -18.13%7.07M | 821.36%8.17M | 560.67%8.08M | 636.63%8.54M | 695.94%8.64M | -32.21%886.42K | -12.35%1.22M | 58.25%1.16M | 19.44%1.09M |
| Shareholders equity without minority interests | 5.41%2.28B | 4.33%2.23B | 3.66%2.2B | 2.59%2.17B | 1.44%2.16B | 0.47%2.13B | 1.94%2.12B | 3.44%2.11B | 6.00%2.13B | 7.43%2.12B |
| Total shareholder equity | 5.41%2.28B | 4.33%2.23B | 3.66%2.2B | 2.59%2.17B | 1.44%2.16B | 0.47%2.13B | 1.94%2.12B | 3.44%2.11B | 6.00%2.13B | 7.43%2.12B |
| Adjustment items of liabilities and equity | ---- | ---- | ---- | ---- | ---- | ---- | -200.00%-0.01 | ---- | ---- | ---- |
| Total liabilityies and equity | 8.19%2.87B | 11.37%2.87B | 11.70%2.83B | 7.05%2.8B | 3.58%2.65B | -0.19%2.57B | 2.24%2.53B | 8.91%2.61B | 10.14%2.56B | 14.37%2.58B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | -- | -- | PwC China (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.